Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Critical Care
Published in: Critical Care 1/2006

Open Access 01-02-2006 | Research

Effect of oral decontamination with chlorhexidine on the incidence of nosocomial pneumonia: a meta-analysis

Published in: Critical Care | Issue 1/2006

Login to get access

Abstract

Introduction

Nosocomial pneumonia is a significant cause of in-hospital morbidity and mortality. Oral care interventions have great potential to reduce the occurrence of nosocomial pneumonia. Studies using topical antiseptic agents yielded mixed results. We hypothesized that the use of chlorhexidine for oral decontamination would reduce the incidence of nosocomial pneumonia in patients requiring mechanical ventilation.

Methods

This study is a meta-analysis of randomized controlled trials assessing the effect of chlorhexidine on the incidence of nosocomial pneumonia. Data sources were Medline, EMBASE, Cochrane library, citation review of relevant primary and review articles, and contact with expert informants. Out of 1,251 articles screened, 4 randomized, controlled trials were identified that included a total of 1,202 patients. Descriptive and outcome data were extracted by two reviewers independently. Main outcome measures were the incidence of nosocomial pneumonia, and mortality. A random effects model was used.

Results

The incidence of nosocomial pneumonia in the control group was 7% (41 out of 615) compared to 4% (24 out of 587) in the treatment group. Gram-negative bacteria accounted for 78% of the total isolates, with Pseudomonas aeruginosa being the most frequently isolated pathogen irrespective of the intervention provided. Duration of mechanical ventilation and intensive care unit length of stay were comparable between the two groups. Overall, the use of oral decontamination with chlorhexidine did not affect the incidence of nosocomial pneumonia (odds ratio of 0.42; 95% confidence interval 0.16–1.06) or the mortality rate (odds ratio 0.77, 95% confidence interval 0.28–2.11).

Conclusion

The use of oral decontamination with chlorhexidine did not result in significant reduction in the incidence of nosocomial pneumonia in patients who received mechanical ventilation, nor altered the mortality rate. The lack of benefit may reflect the few studies conducted in this area. Future trials should focus on a combination strategy of mechanical and pharmacological interventions.
Appendix
Available only for authorised users
Literature
1.
Kollef MH: Prevention of hospital-associated pneumonia and ventilator-associated pneumonia. Crit Care Med 2004, 32: 1396-1405. 10.1097/01.CCM.0000128569.09113.FBCrossRefPubMed
2.
Osmon SB, Kollef MH: Prevention of pneumonia in the hospital setting. Clin Chest Med 2005, 26: 135-142. 10.1016/j.ccm.2004.10.008CrossRefPubMed
3.
Arozullah A, Khuri S, Henderson W, Daley J, Participants in the National Veterans Affairs Surgical Quality Improvement Program: Development and validation of a multi-factorial risk index for predicting postoperative pneumonia after major noncardiac surgery. Ann Intern Med 2001, 135: 847-857.CrossRefPubMed
4.
Fourrier F, Duvivier B, Boutigny H, Rourrel-Delvallez M, Chopin C: Colonization of dental plaque: a source of nosocomial infections in intensive care unit patients. Crit Care Med 1998, 26: 301-308. 10.1097/00003246-199802000-00032CrossRefPubMed
5.
Garrouste-Ortegas M, Chevret S, Arlet G, Marie O, Rouveau M, Popoff N, Schlemmer B: Oropharyngeal or gastric colonization and nosocomial pneumonia in adult intensive care unit patients: a prospective study based on genomic DNA analysis. Am J Respir Crit Care Med 1997, 156: 1647-1655.CrossRef
6.
El-Solh A, Pietrantoni C, Bhat A, Okada M, Zambon J, Aquilina A, Berbary E: Colonization of dental plaques: A reservoir of respiratory pathogens for hospital-acquired pneumonia in institutionalized elders. Chest 2004, 126: 1575-1582. 10.1378/chest.126.5.1575CrossRefPubMed
7.
Munro C, Grap MJ: Oral health and care in the intensive care unit: state of the science. Am J Crit Care 2004, 13: 25-33.PubMed
8.
Veksler A, Kayrouz G, Newman M: Reduction of salivary bacteria by preprocedural rinses with chlorhexidine 0.12%. J Periodontol 1991, 62: 649-651.CrossRefPubMed
9.
DeRiso A, Ladowski J, Dillon T, Justice J, Peterson A: Chlorhexidine gluconate 0.12% oral rinse reduces the incidence of total nosocomial respiratory infection and nonprophylactic systemic antibiotic use in patients undergoing heart surgery. Chest 1996, 109: 1556-1561.CrossRefPubMed
10.
Fourrier F, Cau-Pottier E, Boutigny H, Roussel-Delvallez M, Jourdain M, Chopin C: Effects of dental plaque antiseptic decontamination on bacterial colonization and nosocomial infections in critically ill patients. Intensive Care Med 2000, 26: 1239-1247. 10.1007/s001340000585CrossRefPubMed
11.
Fourrier F, Dubois D, Pronnier P, Herbecq P, Leroy O, Desmettre T, Pottier-Cau E, Boutigny H, Di Pompeo C, Durocher A, Roussel-Delvallez M, for the PIRAD Study Group: Effect of gingival and dental plaque antiseptic decontamination on nosocomial infections acquired in the intensive care unit: A double-blind placebo controlled multicenter study. Crit Care Med 2005, 33: 1728-1735. 10.1097/01.CCM.0000171537.03493.B0CrossRefPubMed
12.
Houston S, Hougland P, Anderson J, LaRocco M, Kennedy V, Gentry L: Effectiveness of 0.12% chlorhexidine gluconate oral rinse in reducing prevalence of nosocomial pneumonia in patients undergoing heart surgery. Am J Crit Care 2002, 11: 567-570.PubMed
13.
Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF: Improving the quality of reports of meta-analyses of randomized controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet 1999, 354: 1896-1900. 10.1016/S0140-6736(99)04149-5CrossRefPubMed
14.
Juni P, Witschi A, Bloch R, Egger M: The hazards of scoring the quality of clinical trials for meta-analysis. JAMA 1999, 282: 1054-1060. 10.1001/jama.282.11.1054CrossRefPubMed
15.
Higgins JP, Thompson SG: Quantifying heterogeneity in a meta-analysis. Stat Med 2002, 21: 1539-1558. 10.1002/sim.1186CrossRefPubMed
16.
17.
Genuit T, Bochicchio G, Napolitano L, McCarter R, Roghman M: Prophylactic chlorhexidine oral rinse decreases ventilator-associated pneumonia in surgical ICU patients. Surg Infect (Larchmt) 2001, 2: 5-18. 10.1089/109629601750185316CrossRef
18.
Rodriguez Artalejo F, Garcia Caballero J, Aguado Matorras A, del Rey Calero R: Oral lavage with chlorhexidine and hospital pneumonia. Med Clin (Barc) 1987, 89: 36.
19.
Grap M, Munro C, Elswick R, Sessler C, Ward K: Duration of action of a single early oral application of chlorhexidine on oral microbial flora in mechanically ventilated patients: A pilot study. Heart Lung 2004, 33: 83-91. 10.1016/j.hrtlng.2003.12.004CrossRefPubMed
20.
Bonten MJ, Bergmans DC, Ambergen AW, de Leeuw PW, van der Geest S, Stobberingh EE, Gaillard CA: Risk factors for pneumonia and colonization of respiratory tract and stomach in mechanically ventilated ICU patients. Am J Respir Crit Care Med 1996, 154: 1339-1346.CrossRefPubMed
21.
Sole ML, Poalillo FE, Byers JF, Ludy JE: Bacterial growth in secretions and on suctioning equipment of orally intubated patients: a pilot study. Am J Crit Care 2002, 11: 141-149.PubMed
22.
Longman L, Higham S, Bucknall R, Kaye S, Edgar W, Field E: Signs and symptoms in patients with salivary gland hypofunction. Postgrad Med J 1997, 73: 93-97.PubMedCentralCrossRefPubMed
23.
Loesche W, Schork A, Terpenning M, Chen Y, Stoll J: Factors which influence levels of selected organisms in saliva of older individuals. J Clin Microbiol 1995, 33: 2550-2557.PubMedCentralPubMed
24.
Prince AS: Biofilms, antimicrobial resistance, and airway infection. N Engl J Med 2002, 347: 1110-1111. 10.1056/NEJMcibr021776CrossRefPubMed
25.
Costerton W, Veeh R, Shirtliff M, Pasmore M, Post C, Ehrlich G: The application of biofilm science to the study and control of chronic bacterial infections. J Clin Invest 2003, 112: 1466-1477. 10.1172/JCI200320365PubMedCentralCrossRefPubMed
26.
Adair C, Gorman S, Feron B, Byers LM, Jones DS, Goldsmith CE, Moore JE, Kerr JR, Curran MD, Hogg G, et al.: Implications of endotracheal tube biofilm for ventilator-associated pneumonia. Intensive Care Med 1999, 25: 1072-1076. 10.1007/s001340051014CrossRefPubMed
Metadata
Title
Effect of oral decontamination with chlorhexidine on the incidence of nosocomial pneumonia: a meta-analysis
Publication date
01-02-2006
Published in
Critical Care / Issue 1/2006
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc4837

Other articles of this Issue 1/2006

Critical Care 1/2006 Go to the issue

Research

A comparison of admission and worst 24-hour Acute Physiology and Chronic Health Evaluation II scores in predicting hospital mortality: a retrospective cohort study

Book report

Alvarez A (Editor-in-Chief), Brodsky J, Alpert M, Cowan G (Associated Editors): Morbid Obesity: Peri-operative Management. New York: Cambridge University Press

Research

The impact of empiric antimicrobial therapy with a β-lactam and fluoroquinolone on mortality for patients hospitalized with severe pneumonia

Commentary

Information technology issues during and after Katrina and usefulness of the Internet: how we mobilized and utilized digital communications systems

Editorial

Falling towers, crumbling levees, and viral mutations

Research

Clinical relevance of Aspergillus isolation from respiratory tract samples in critically ill patients